VIKING GLOBAL INVESTORS LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,366,385 (Position Closed) | Filing |
| 2022-06-10 4:15 pm Purchase | 2022-05-31 | 13G | Celldex Therapeutics, Inc. CLDX | VIKING GLOBAL INVESTORS LP | 2,366,385 5.100% | 2,366,385 (New Position) | Filing |